EVALUATING EUROPEAN DATA SOURCES FOR ASSESSING REAL-WORLD EFFECTIVENESS OF NEW ANTI-DIABETIC DRUGS

被引：0
|
作者：
Moise, P. [1 ]
Andreykiv, M. [2 ]
van Engen, A. [2 ]
Wimbush, A. J. [3 ]
Richards, A. [3 ]
Ploug, U. J. [4 ]
机构：
[1] Quintiles Global Consulting, Levallois Perret, Ile De France, France
[2] Quintiles Global Consulting, Hoofddorp, Noord Holland, Netherlands
[3] Novo Nordisk AS, Zurich Oerlikon, Switzerland
[4] Novo Nordisk AS, Soborg, Denmark
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1491
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A464 / A465
页数：2
相关论文
共 50 条
  • [31] A Discussion of Data Requirements and Methodologic Considerations for Evaluating the Real-World Effectiveness and Safety of Biosimilar Medicines
    Kugener, Veronique
    Kelsh, Michael
    Bradbury, Brian
    Giezen, Thijs
    Bosco, Jaclyn
    Trifiro, Gianluca
    Golembesky, Amanda
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 281 - 282
  • [32] New findings on the effects of diabetes and anti-diabetic drugs on prostate cancer
    Lee, Guk Jin
    Han, Kyungdo
    Lee, Seong-Su
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11): : 5446 - 5455
  • [33] New approaches in research and development of anti-diabetic drugs: an industry perspective
    Maas, Jochen
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2012, 3 (04) : 109 - 112
  • [34] Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data
    Takabayashi, Katsuhiko
    Ando, Fumihiko
    Suzuki, Takahiro
    MODERN RHEUMATOLOGY, 2019, 29 (01) : 87 - 97
  • [35] REAL-WORLD DATA SOURCES FOR ONCOLOGY IN FIVE MAJOR EUROPEAN COUNTRIES: A TARGETED LITERATURE REVIEW
    Liu, C. R.
    Adamson, B.
    Horne, E.
    Sujenthiran, A.
    Meadows, E.
    VALUE IN HEALTH, 2024, 27 (12) : S573 - S573
  • [36] Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg)
    Krauss, Ekaterina
    Tello, Silke
    Wilhelm, Jochen
    Schmidt, Johanna
    Stoehr, Mark
    Seeger, Werner
    Dartsch, Ruth C.
    Crestani, Bruno
    Guenther, Andreas
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 19
  • [37] Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?
    Navarro-Sabate, A.
    Font, R.
    Espinas, J. A.
    Sola, J.
    Martinez-Soler, F.
    Gil-Gil, M.
    Vinas, G.
    Tibau, A.
    Borrell, M.
    Segui, M.
    Margeli, M.
    Servitja, S.
    Perez, C.
    Domenech, M.
    Nava, M.
    Marin, M.
    Gonzalez, S.
    Borras, J. M.
    CANCERS, 2025, 17 (02)
  • [38] ASSESSING THE QUALITY OF REAL-WORLD DATA AND REAL-WORLD EVIDENCE IN ONCOLOGY RESEARCH: A COHESIVE FRAMEWORK FOR RESEARCHERS
    Su, Z.
    Dye, J.
    Wilson, T.
    Amirian, E. S.
    O'Sullivan, A.
    VALUE IN HEALTH, 2023, 26 (06) : S377 - S377
  • [39] Biases in Evaluating the Safety and Effectiveness of Drugs for the Treatment of COVID-19: Designing Real-World Evidence Studies
    Renoux, Christel
    Azoulay, Laurent
    Suissa, Samy
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2021, 190 (08) : 1452 - 1456
  • [40] Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation☆
    Antoine, Alison
    Perol, David
    Robain, Mathieu
    Bachelot, Thomas
    Choquet, Remy
    Jacot, William
    Yahia, Bechir Ben Hadj
    Grinda, Thomas
    Delaloge, Suzette
    Lasset, Christine
    Drouet, Youenn
    EUROPEAN JOURNAL OF CANCER, 2024, 213
12345